MEK162 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function

Clinical trial NCT02050815 · TERMINATED

Trial details

NCT number: NCT02050815
Sponsor: Array Biopharma, now a wholly owned subsidiary of Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2014-03-01
Primary completion: 2016-08-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.